Disclosures for "Food Effect Study of Fosigotifator, an eIF2B Activator being developed as a Potential Treatment for Amyotrophic Lateral Sclerosis, Vanishing White Matter Disease, and Major Depressive Disorder"
-
Dr. Han has received personal compensation for serving as an employee of AbbVie.
-
Dr. Jeong has received personal compensation for serving as an employee of AbbVie. An immediate family member of Dr. Jeong has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Stryker. Dr. Jeong has stock in AbbVie.
-
Dr. Gopalkrishnan has nothing to disclose.
-
Dr. Chaudhary has nothing to disclose.
-
Dr. Zhao has received personal compensation for serving as an employee of AbbVie. Dr. Zhao has stock in AbbVie.
-
Mrs. Saari-Nordhaus has nothing to disclose.
-
Dr. Cho has received personal compensation for serving as an employee of Calico. Dr. Cho has stock in Roche.
-
Dr. Rosebraugh has received personal compensation for serving as an employee of AbbVie Inc. Dr. Rosebraugh has stock in AbbVie Inc..